Market cap
₹10 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
116.7
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
2.2 %
-
ROCE
3 %
-
Industry P/E
29.3
-
EV/EBITDA
79.8
-
Debt to Equity
0
-
Book Value
₹36.3
-
EPS
₹0.1
-
Face value
10
-
Shares outstanding
10,084,800
10 Years Aggregate
CFO
₹-0.16 Cr
EBITDA
₹0.02 Cr
Net Profit
₹0.16 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Omkar Pharmachem
| -- | -40.6 | -63.1 | -61.3 | -22.4 | -- | -- |
|
BSE Commodities
| 7.7 | 0.2 | -1.1 | 12.6 | 14.7 | 8.5 | 13.6 |
|
Company
|
2020
|
|---|---|
|
Omkar Pharmachem
| 17.4 |
|
BSE Small Cap
| 32.1 |
|
BSE Commodities
| 26.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Omkar Pharmachem
|
10.0 | 10.0 | 0.4 | 0.1 | 26.9 | 0.4 | 116.7 | 0.3 |
| 2,011.0 | 10,280.4 | 1,658.3 | 225.2 | 16.3 | 15.1 | 45.7 | 6.3 | |
| 3,760.8 | 16,270.9 | 16,176.5 | 643.0 | 5.0 | 16.1 | 25.3 | 3.8 | |
| 1,427.5 | 18,071.0 | 12,103.5 | 984.9 | 13.1 | 14.7 | 18.4 | 2.5 | |
| 1,239.5 | 5,350.2 | 2,626.0 | 271.8 | 15.7 | 12.5 | 19.7 | 2.3 | |
| 2,229.4 | 7,935.7 | 5,752.3 | 353.8 | 8.2 | 13.8 | 22.4 | 2.7 | |
| 2,352.7 | 7,544.0 | 135.3 | 131.3 | 97.2 | 15.5 | 57.5 | 8.9 | |
| 6,030.0 | 8,169.3 | 2,222.2 | 225.7 | 12.8 | 16.8 | 36.2 | 5.5 | |
| 8,636.0 | 44,306.9 | 3,633.6 | 789.7 | 29.6 | 21 | 56.1 | 10.6 | |
| 633.6 | 16,140.1 | 15,120.0 | -2,079.0 | 3.0 | -0.7 | -- | 0.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Omkar Pharmachem
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
1995
-
Chairman
--
-
Managing Director
Bhawani Shankar Goyal
-
Headquarters
Ahmedabad, Gujarat
-
Website
FAQs for Omkar Pharmachem
What is the current share price of Omkar Pharmachem Ltd Today?
The share price of Omkar Pharmachem Ltd is ₹9.95 (BSE) as of 01-Sep-2026 IST. Omkar Pharmachem Ltd has given a return of -22.37% in the last 3 years.
What is the current PB & PE ratio of Omkar Pharmachem Ltd?
The P/E ratio of Omkar Pharmachem Ltd is 116.68 times as on 01-Sep-2026, a 298 premium to its peers’ median range of 29.30 times.
The P/B ratio of Omkar Pharmachem Ltd is 0.27 times as on 01-Sep-2026, a 88 discount to its peers’ median range of 2.31 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
0.00 |
2024 |
119.87 |
2.46 |
2023 |
127.42 |
2.79 |
2022 |
112.33 |
2.33 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Omkar Pharmachem Ltd?
The 52-week high and low of Omkar Pharmachem Ltd are Rs 29.74 and Rs 9.95 as of 02-Sep-2026.
What is the market cap of Omkar Pharmachem Ltd?
Omkar Pharmachem Ltd has a market capitalisation of ₹ 10 Cr as on 01-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Omkar Pharmachem Ltd?
Before investing in Omkar Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.